Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$16.52 - $20.4 $349,398 - $431,459
-21,150 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$16.86 - $23.44 $4.25 Million - $5.9 Million
-251,865 Reduced 92.25%
21,150 $490,000
Q1 2020

May 14, 2020

BUY
$14.47 - $27.96 $388,736 - $751,145
26,865 Added 10.91%
273,015 $4.87 Million
Q3 2019

Nov 12, 2019

BUY
$16.91 - $36.27 $2.23 Million - $4.79 Million
132,150 Added 115.92%
246,150 $4.48 Million
Q2 2019

Aug 14, 2019

SELL
$31.0 - $36.3 $527,000 - $617,100
-17,000 Reduced 12.98%
114,000 $4.06 Million
Q1 2019

May 14, 2019

BUY
$31.58 - $46.35 $3.22 Million - $4.73 Million
102,000 Added 351.72%
131,000 $4.4 Million
Q4 2018

Feb 12, 2019

BUY
$30.43 - $56.65 $547,740 - $1.02 Million
18,000 Added 163.64%
29,000 $953,000
Q3 2018

Nov 13, 2018

BUY
$46.46 - $68.49 $511,060 - $753,390
11,000 New
11,000 $671,000
Q2 2018

Aug 10, 2018

SELL
$46.25 - $104.45 $1.02 Million - $2.3 Million
-22,000 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$57.4 - $108.44 $3.16 Million - $5.96 Million
-55,000 Reduced 71.43%
22,000 $2.34 Million
Q4 2017

Feb 09, 2018

SELL
$23.02 - $60.5 $184,160 - $484,000
-8,000 Reduced 9.41%
77,000 $4.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
85,000
85,000 $1.66 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.